What will the average number of measles cases be during Trump's term?
Assuming the market's binary is whether the 2025–2028 average annual measles cases will be ≥1,000, I assess a 72% chance that the average will meet or exceed 1,000 cases/year.
Analysis
**Stage 1 — Blind analysis (ignoring market price; explicit assumption)**
*Assumption:* The market’s binary 'Yes'/ 'No' question is not shown in the prompt. To produce a concrete assessment I adopt a single, explicit working assumption: **'Yes' = the average number of confirmed U.S. measles cases across 2025, 2026, 2027, and 2028 is ≥ 1,000 cases per year**. If the true market threshold differs, the probabilities below should be reweighted accordingly.
Given that assumption, I evaluate the outlook based on the factual datapoint provided and historical patterns. As of July 2, 2026 there are **2,170 confirmed cases in 2026** (year-to-date by early July per the summary). That alone strongly suggests that the 2026 full-year total will be at, or well above, 2,170 unless transmission abruptly stops for the remainder of the year. Historical context: large U.S. measles outbreaks have occurred in single years (e.g., 2019 had ~1,282 cases), and multi-year variance is substantial when importations and clusters take hold. Measles transmission is highly sensitive to local vaccination coverage and clustering of susceptible individuals; a single large outbreak year can push a four-year average above 1,000 even if other years are modest.
Key factual inferences under the assumption: - If 2026 finishes even near the year-to-date level (2,500–3,000+), two scenarios will produce a ≥1,000 four-year average: (A) at least one other year above ~500–1,000, or (B) more than one year moderately elevated. If 2025 was non-trivial (several hundred+), the threshold is already plausibly crossed. - Immunological dynamics: a big 2026 outbreak reduces susceptibles in later years locally, but measles susceptibility is replenished through birth cohorts and pockets of low vaccine uptake; this makes sustained multi-year high incidence possible but not certain.
Balancing these forces, and ignoring current market pricing, my independent estimate that the 4‑year average ≥1,000 is 72%. That reflects high weight on the confirmed 2026 surge (2,170 by July) and medium weight on likelihood of repeated or additional outbreaks across 2025–2028 given current epidemiological and social conditions.
**Stage 2 — Market calibration (considering current market prices)**
The market prices show Yes=0.30, No=0.70. That is materially lower than my independent 72% estimate under the ≥1,000 assumption. Possible reasons the market trades lower:
- **Different threshold:** Traders may be interpreting the binary threshold as substantially higher than 1,000 (e.g., ≥2,000 or ≥3,000 average), in which case my assumption misaligns with the market and the low Yes price is consistent. - **Information lag / data interpretation:** Some traders may think the 2,170 figure is year-to-date limited to specific outbreak clusters or is likely to be revised downward, or they may suspect reporting artifacts. If traders believe 2,170 is not representative of a sustained national surge, they will price Yes lower. - **Conservatism / risk aversion:** Markets often underweight tail risks and institutional traders may be conservative relative to an analyst who gives greater weight to a single strong datapoint. - **Hedging and liquidity dynamics:** Large volume (148k contracts) can reflect a mix of speculative flows and hedges; prices may be depressed by concentrated selling unrelated to fundamentals (e.g., portfolio rebalancing).
If the true binary threshold equals my working assumption (≥1,000), then the market appears to be underpricing the probability of Yes. The gap (72% vs 30%) suggests a mispricing opportunity contingent on (a) confirmation that 2026 final counts remain elevated through year end and (b) evidence that 2025 was not uniformly negligible. If instead the market's threshold is higher than my assumption, the apparent mispricing largely resolves.
Actionable implication: Before trading against the market, verify the contract’s defined numerical threshold. If it is indeed ~1,000, I would view the market price as an overly pessimistic assessment and place a contrarian position favoring Yes; if the threshold is higher, update the model accordingly.
Arguments
For
- 2026 is already very large (2,170 by July 2), implying the full-year total is likely to be far above 1,000 unless transmission stops immediately.
- Measles is highly transmissible and will produce outsized increases in case counts when pockets of low vaccination and importations coincide; one or two such outbreaks across 4 years can push the average above 1,000.
- Trends since the COVID-era disruptions show pockets of under-vaccination and growing misinformation; these social drivers increase outbreak risk over multiple years.
- U.S. population dynamics (birth cohorts with variable vaccine coverage) and travel patterns sustain seeding risk year-to-year, increasing chance of repeated outbreaks.
Against
- A single very large 2026 outbreak could be balanced by three relatively quiet years (especially if 2025 and 2027–2028 have low incidence), producing an average below 1,000.
- Rapid, well-targeted public health interventions (catch-up vaccination campaigns, school exclusion policies) can blunt ongoing transmission and prevent repeat large outbreaks.
- Natural depletion of susceptible pockets after a big 2026 outbreak could markedly reduce cases in subsequent years, lowering the four-year average.
- Data uncertainty: if 2,170 is partial-year and concentrated in a few clusters, full-year extrapolations and future years may still fall short of sustaining a high multi-year average.
Key drivers
- 2026 confirmed cases (2,170 by July 2, 2026) — magnitude and whether this is year-to-date or final-year trend
- 2025 baseline level (unknown) — whether 2025 had substantial outbreaks or was quiet
- Likelihood of continued transmission/remnant pockets and local vaccination coverage / clustering
- Importation pressure and travel patterns (seeding of outbreaks)
- Public health response speed and scale, including outbreak containment and vaccination campaigns
Risk factors
- Data ambiguity: the 2,170 figure may be year-to-date through July (raising the full-year projection) or mischaracterized; reporting revisions are possible
- Single-year spike dynamics: a large 2026 outbreak could be a one-off, with other years low enough to pull the four-year average below threshold
- Behavioral change and policy: renewed vaccination campaigns, increased MMR uptake or emergency interventions could sharply reduce cases in 2027–2028
- Herd immunity effects: a big outbreak can temporarily reduce susceptibles, lowering incidence in subsequent years and reducing the four-year average
Scenarios
Best case
Sustained high incidence scenario: 2026 finishes ~3,000+ cases, 2025 was moderate (≥800), and 2027–2028 see repeated outbreaks or at least one additional medium-sized outbreak (≥1,000). The four-year average comfortably exceeds 1,000 (likely 1,500–2,000+). This maps to my highest-confidence outcome for 'Yes.'
Most likely
A mixed scenario where 2026 is high (final >2,000), 2025 is low-to-moderate (a few hundred), and 2027–2028 have moderate, possibly localized outbreaks. The four-year average clusters around 1,000–1,500, yielding a modestly favorable outcome for the ≥1,000 threshold — consistent with my 72% Yes probability under the stated assumption.
Worst case
One-off spike scenario: 2026 is an unusual concentrated outbreak that inflates year-to-date counts but 2025 was very low and aggressive public-health responses plus post-outbreak immunity suppress 2027–2028 to very low levels. The four-year average falls below 1,000 (e.g., 300–800), producing a 'No' outcome.
More from this day
- pop culturePolymarketEnded
What will the announcers say during Switzerland vs Colombia World Cup Match?
AI3%MKT76%Edge-73HypedVery unlikely that FOX's official English announcers will utter the standalone word "Goal" 60 or more times during regulation play, extra time, or penalties; I assess this at roughly a 3% chance given typical match commentary patterns and plausible high-goal scenarios.
- pop culturePolymarketEnded
What will happen before GTA VI?
AI1%MKT51%Edge-50HypedI assess that the probability of a WHO-level or widely recognized global pandemic being declared before the market cutoff (2026-07-31) is very low; I estimate about a 1% chance given the short time window and improved post‑COVID surveillance and response capacity.
- FinancialsKalshi13y
Will OpenAI or Anthropic IPO first?
AI35%MKT80%Edge-45Hyped**Assumption:** 'Yes' = OpenAI will IPO before Anthropic. Independent assessment: I assign a 35% probability that OpenAI will IPO before Anthropic (i.e., Anthropic is more likely to be the first of the two to list).